Working... Menu

Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03124433
Recruitment Status : Active, not recruiting
First Posted : April 21, 2017
Last Update Posted : April 9, 2019
Information provided by (Responsible Party):
Lee Lui Shiong, Singapore General Hospital

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : June 1, 2019
  Estimated Study Completion Date : June 30, 2019